1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Motherisk Update 2014
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting,
Details to be announced
- Read more in our News Archive
Current Studies at Motherisk
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Environmental Exposures and Children's Health
Alcohol Use during Pregnancy
Control of Hypertension in Pregnancy Study
Folic Acid Before and During Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
The Cancer in Pregnancy ForumArchived Questions and Answers
This Forum has been the centre of an exceptional exchange of knowledge diagnosis, treatment, symptoms and other effects of cancer during pregnancy and lactation. All are welcome to review the Questions and Answers posted here, provided that they acknowledge and accept the important proviso and disclaimer below.
i AM CURRENTLY USING ROXICODONE 15-30MG EVERY 4-6 HOURS, I HAVE BEEN USING THIS MED FOR MY CONDITION FOR YEARS...I FOUND OUT I WAS PREGNANT IN JUNE AND HAVE BEEN ADVISED NOT TO DISCONTINUE USE AS WITHDRAWALS MAY AFFECT MY UNBORN BABY...I HAVE DONE EXTENSIVE INTERNET RESEARCH AND CANNOT FIND ANY INFO SUGGESTING USE OF THIS DRUG BEING DETRIMENTAL TO MY BABY...ARE THERE ANY FETAL RISKS THAT I AM NOT SEEING? PLEASE HELP.
The following information should not replace the assessment and advice you have been receiving from your physician (cancer specialist, obstetrician, or any other healthcare provider). It is offered for your information only. Consult your physician.
This drug is not known to be teratogenic, but after prolonged fetal exposure, the newborn may experience withdrawal and should be monitored by a pediatrician.